Answers are grounded in this paper and cite their sources.
Expert consensus outlines treatment and diagnostic strategies for HIV-related diffuse large B cell lymphoma, suggesting standardized protocols for clinical practice.
Human immunodeficiency virus infection related diffuse large B cell lymphoma (HIV(+) DLBCL) exhibits a low incidence and a challenging diagnosis, with a lack of standardized treatment protocols. To improve the understanding of HIV(+) DLBCL among clinical physicians in China and enhance diagnostic and treatment levels, the Lymphoid Disease Group, Chinses Society of Hematology, Chinese Medical Association, Lymphoma Integrative Rehabilitation Professional Committee of Chinese Anti-Cancer Association (CACA) and the Central and Western China AIDS Lymphoma League (CALL), Lymphoma Expert Committee of Chinese Society of Clinical Oncology (CSCO) have organized relevant experts to formulate this consensus.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: